Ohio State Among First to Test Normothermic Ex-Vivo Perfusion of Extended Criteria Donor Hearts

The Ohio State University Wexner Medical Center is among the first to test ex-vivo organ perfusion of extended criteria donor hearts.

Normothermic Machine Preservation of the Liver: State of the Art

Ex Vivo Normothermic Machine Perfusion Is Safe, Simple, and Reliable: Results From a Large Animal Model - Ahmed Nassar, Qiang Liu, Kevin Farias, Giuseppe D'Amico, Cynthia Tom, Patrick Grady, Ana Bennett, Teresa

Cells, Free Full-Text

Innovations in Organ Transplants

Machine perfusion combined with antibiotics prevents donor-derived infections caused by multidrug-resistant bacteria - American Journal of Transplantation

Current status and outcomes in heart transplantation: a narrative review

Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial - The Lancet

Full article: Normothermic ex-vivo liver perfusion: where do we stand and where to reach?

Encouraging New Results from Normothermic Machine Perfusion – Consult QD

Normothermic donor heart perfusion: current clinical experience and the future - Messer - 2015 - Transplant International - Wiley Online Library

Ex Vivo Normothermic Machine Perfusion Is Safe, Simple, and Reliable: Results From a Large Animal Model - Ahmed Nassar, Qiang Liu, Kevin Farias, Giuseppe D'Amico, Cynthia Tom, Patrick Grady, Ana Bennett, Teresa

Frontiers Publishing Partnerships Sense and Sensibilities of Organ Perfusion as a Kidney and Liver Viability Assessment Platform

Frontiers Renal Delivery of Pharmacologic Agents During Machine Perfusion to Prevent Ischaemia-Reperfusion Injury: From Murine Model to Clinical Trials

Primary graft dysfunction following lung transplantation: From pathogenesis to future frontiers

Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial - The Lancet